ETST Investor Presentation
Earth Science Tech, Inc. CEO to Present at Planet MicroCap Las Vegas Conference in 2026
Earth Science Tech, Inc. (ETST) will take the stage at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026, at 9:00 AM PT. CEO and Chairman Giorgio R. Saumat will present at the Bellagio Resort & Hotel in Las Vegas, according to MarketScreener.
The presentation marks a public milestone for ETST's sharp pivot away from CBD products toward a vertically integrated healthcare model. The company reported $8.4 million in revenue and $910,000 in net income for its most recent quarter — a 341% jump in profit year-over-year, per OTC Markets.
From CBD Startup to Pharmaceutical Holding Company
ETST was once a small CBD and nutraceutical company. That changed in February 2023, when Giorgio Saumat took over as CEO. He agreed to take zero pay until the company turned cash-flow positive, according to Simply Wall St. He then redirected the business toward compounding pharmacies and telehealth.
On January 6, 2026, ETST formally changed its industry code to SIC 2834 — the classification for pharmaceutical preparations — dropping its legacy CBD identity, per GlobeNewswire. Saumat describes the company as a "matchmaking engine" for patient care, built to "acquire or roll in different businesses, turn them around, operate them, generate cash, and then reinvest that cash," as reported by The Wall Street Analyzer.
Strong Profits Drive Push for Institutional Investors
ETST's financials have quietly improved. Net income for fiscal 2025 reached $3.3 million, according to StockTitan. Management now forecasts net income of $4.7 million for fiscal 2026 — a 40%-plus increase. The company also targets $1.4 million in annualized cost savings through subsidiary consolidation.
Gross margins top 73%, and the company carries a debt-to-equity ratio of just 0.7%, per Simply Wall St. CEO Saumat personally owns 122,680,127 shares, a stake he added to in January 2025 when he bought 787,500 more, per TradingView. The conference appearance is part of a stated "institutional-ready" push.
Telehealth Launch Completes a Vertical Healthcare Loop
In March 2026, ETST launched MyOnlineConsultation.com, a telehealth platform. Combined with its pharmacy brands — RxCompoundStore.com and Mister Meds — ETST now controls the full patient journey. A patient can consult a doctor online, get a prescription, and have it filled through one of ETST's own pharmacies, per FinanceWire.
This vertical model matters because it cuts out third-party referral layers. That helps protect margins. However, the DEA's temporary extension of telehealth prescribing rules runs only through late 2026. Analysts call this a "telemedicine cliff" — a regulatory deadline that could disrupt the business model if not resolved.
Regulatory Headwinds and Bearish Warnings Cloud the Outlook
ETST's growth story comes with real risks. The FDA issued 30 warning letters to telehealth firms in early 2026 over the marketing of compounded GLP-1 drugs — the weight-loss medications at the center of a healthcare boom — according to Venable LLP. ETST operates directly in this space.
Sentiment is split. Simply Wall St praises ETST's margins and balance sheet, calling it a rare profitable microcap. But StockScan projects an 11.5% price downside and labels the stock a speculative hold. Low trading volume on the OTC market means large price swings are possible on little news, per StockInvest.us.
Sentiment
NeutralPublishers
4
Articles
4
Reach
4
